Man Arrested on Federal Charges of Selling Fake Pills that caused Fatal Fentanyl Overdose
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Sobrescribir enlaces de ayuda a la navegación

  • Inicio
  • Man Arrested on Federal Charges of Selling Fake Pills that caused Fatal Fentanyl Overdose

Man Arrested on Federal Charges of Selling Fake Pills that caused Fatal Fentanyl Overdose

Agosto 01, 2022
|
Share Article
|
Download Press Release
For Immediate Release
Contact: Rosa Valle-Lopez
Phone Number: (571) 387-5045

Arrested picture with handcuffs
Arrested Generic Pic.jpg

LOS ANGELES – A Paso Robles man has been arrested on federal charges of selling counterfeit prescription pills containing fentanyl to a 19-year-old Atascadero resident who suffered a fatal overdose from the synthetic opioid, the Justice Department announced today.

Timothy Clark Wolfe, 24, was taken into custody Thursday by special agents with the Drug Enforcement Administration, and he was arraigned on the federal charges this afternoon in United States District Court in downtown Los Angeles.

A federal grand jury on July 19 charged Wolfe in a two-count indictment that accuses him of distributing fentanyl resulting in death and possession with the intent to distribute alprazolam (often sold under the brand name Xanax).

Wolfe pleaded not guilty to the charges in the indictment and a September 20 trial date was scheduled. A federal magistrate judge ordered Wolfe released on $150,000 bond.

The indictment alleges that, on March 8, 2020, Wolfe sold the victim the fentanyl-laced pills, “the use of which resulted in the death and serious bodily injury of E.V.”

During a search of Wolfe’s residence the following day after the death of E.V., Atascadero Police discovered the alprazolam, which the indictment alleges he intended to distribute.

 The San Luis Obispo County District Attorney’s Office charged Wolfe in relation to the overdose death on May 20, 2020. The District Attorney’s Office will dismiss their state charges in light of the federal prosecution. 

An indictment contains allegations that a defendant has committed a crime. Every defendant is presumed innocent until and unless proven guilty beyond a reasonable doubt.

The charge of distributing fentanyl resulting in death carries a mandatory minimum sentence of 20 years in federal prison and a maximum statutory penalty of life. The charge of possession with the intent to distribute alprazolam carries a maximum statutory penalty of five years in federal prison.

The DEA’s Los Angeles Field Office is investigating this matter. The Atascadero Police Department and the San Luis Obispo County District Attorney’s Office provided substantial assistance.

Assistant United States Attorneys Julia Hu of the Major Frauds Section and Jena MacCabe of the General Crimes Section are prosecuting this case.

The Centers for Disease Control and Prevention estimates that 108,642 people died as the result of a drug overdose in the United States during the one-year period ending February 2022. Synthetic opioids, such as fentanyl and its analogs, are the primary driver of the increase in drug overdose deaths. Synthetic opioids are involved in 67% of all drug overdose deaths and 89% of opioid-involved drug overdose deaths.

According to the DEA, criminal drug networks in Mexico are mass-producing illicit fentanyl and fake pills pressed with fentanyl in clandestine, unregulated labs. These fake pills are designed to look like real prescription pills, typically replicating prescription opioid medications such as oxycodone (common brand names include Oxycontin and Percocet) and hydrocodone (Vicodin); sedatives such as alprazolam; and stimulants (Adderall). The DEA warns that pills purchased outside of a licensed pharmacy are illegal, dangerous and potentially lethal. For more information, please visit www.dea.gov/onepill.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Brian M. Clark Special Agent in Charge - Los Angeles
@dealosangeles
  • Facebook
  • X
  • Email
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster